Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma

Mahdi Haider; Xiu Joanne; Reddy Sandeep K.; DeBernardo Robert

首页> 外文期刊>Journal of Surgical Oncology >Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma

【24h】

Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma

机译：与卵巢浆液性癌相比，子宫浆液性癌中PI3K / mTOR，MAPK通路和Her2表达/扩增的改变更为常见

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectivesTo compare the molecular profile of a large cohort of uterine papillary serous carcinoma (UPSC) and ovarian serous carcinoma (EOC-S).

机译：目的比较大组子宫乳头状浆液性癌（UPSC）和卵巢浆液性癌（EOC-S）的分子谱。

著录项

来源
《Journal of Surgical Oncology 》 |2015年第2期| 共7页
作者
Mahdi Haider; Xiu Joanne; Reddy Sandeep K.; DeBernardo Robert;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词
uterine papillary serous carcinoma; serous ovarian carcinoma; molecular profile; PI3K; AKT; mTOR; BRCA; HER2; neu; CARIS;

机译：子宫乳头状浆液性癌;浆液性卵巢癌;分子结构;PI3K;AKT;mTOR;BRCA;HER2;neu;CARIS;

相似文献

外文文献
中文文献
专利

1. Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma [J] . Mahdi Haider, Xiu Joanne, Reddy Sandeep K., Journal of Surgical Oncology . 2015 ,第2期

机译：与卵巢浆液性癌相比，子宫浆液性癌中PI3K / mTOR，MAPK通路和Her2表达/扩增的改变更为常见
2. Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets [J] . Chen Shuhui, Cavazza Elisa, Barlier Catherine, Oncology letters . 2016 ,第5aPta1期

机译：除了P53和PTEN之外：鉴定高级浆液卵巢癌中RAS / MAPK和PI3K / AKT信号传导途径的分子改变，以确定潜在的新疗效目标
3. Expression of the PI3K/AKT/mTOR pathway as a prognostic factor in patients with advanced high grade serous ovarian carcinoma treated with neoadjuvant chemotherapy [J] . Cierniak S., Koktysz R., Jesiotr M., European journal of gynaecological oncology . 2019 ,第5期

机译：PI3K / AKT / MTOR途径的表达作为新辅助化疗治疗高级浆膜卵巢癌患者的预后因素
4. Global proteomic analysis of ovarian high-grade serous carcinomas using SWATH-MS for targeted verification of proteome changes associated with genomic alterations [C] . Stefani N. Thomas, Jing Chen, Paul Aiyetan, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：卵巢高级浆液癌的全局蛋白质组学分析使用SWATH-MS进行靶向验证与基因组改变相关的蛋白质组变化
5. The Impact of Chromosomal Aberrations on the Regulation of Kallikrein 6 Expression in Serous Ovarian Carcinoma. [D] . Bayani, Jane Marie. 2013

机译：染色体畸变对浆液性卵巢癌中激肽释放酶6表达调控的影响。
6. Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets [O] . Shuhui Chen, Elisa Cavazza, Catherine Barlier, -1

机译：除了P53和PTEN：鉴定高级别浆液性卵巢癌中RAS / MAPK和PI3K / AKT信号通路的分子改变以确定潜在的新型治疗靶标
7. Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets [O] . Chen, Shuhui, Cavazza, Elisa, Barlier, Catherine, 2016

机译：除了P53和PTEN：鉴定高级别浆液性卵巢癌中RAS / MAPK和PI3K / AKT信号通路的分子改变，以确定潜在的新型治疗靶标
8. Pathogenesis of Ovarian Serous Carcinoma as the Basis for Immunologic Directed Diagnosis and Treatment. Project 1 - Molecular Characterization of Ovarian Serous Tumors Developing Along Different Pathways [R] . Kurman, R. J. , Shih, I. 2003

机译：卵巢浆液性癌的发病机制是免疫定向诊断和治疗的基础。项目1 - 沿不同途径发展的卵巢浆液性肿瘤的分子特征

Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅